JPRN-jRCT2080220855未知2 期
ong-term administration study of KW-6485P for pediatric patients (extension from pharmacokinetic study)
Kyowa Hakko Kirin Co., Ltd.0 个研究点目标入组 25 人开始时间: 2009年9月9日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 发起方
- 入组人数
- 25
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 2age old 至 <= 15age old（—）
- 性别
- All
入选标准
- •Patients who have completed and been eligible for the pharmacokinetic study of KW-6485P for pediatric patients
- •Patients who have provided written informed consent from guardian
排除标准
- •Patients who did not reliably complete their epileptic seizure record in the pharmacokinetic study of KW-6485P for pediatric patients
研究者
相似试验
未知
3 期
ong-term study of KW-6485P (6485P-005)Symptomatic or cryptogenic localization-related epilepsyJPRN-jRCT2080221336Kyowa Hakko Kirin Co., Ltd.60
未知
3 期
ong-Term Safety Study of KW-6002 (6002-010)Parkinson's DiseaseJPRN-jRCT2080220821Kyowa Hakko Kirin Co., Ltd.150
未知
3 期
Placebo-Controlled Double-Blind Crossover Comparative Study of KW-6500 (6500-004)Parkinson's DiseaseJPRN-jRCT2080220980Kyowa Hakko Kirin Co., Ltd.20
已完成
2 期
A Study of KW-6356 in Patients With Parkinson's Disease on Treatment With Levodopa-containing PreparationsParkinson's DiseaseJPRN-jRCT2080224050Kyowa Kirin Co., Ltd.486
未知
3 期
Phase III study of KW-6485P (6485P-004)JPRN-jRCT2080221158Kyowa Hakko Kirin Co., Ltd.60